Concise health risk tracking scale: A brief self-report and clinician rating of suicidal risk

Journal of Clinical Psychiatry

Volumn 72, Issue 6, 2011, Pages 757-764

  Trivedi, Madhukar H ^a   Wisniewski, Stephen R ^b   Morris, David W ^a   Fava, Maurizio ^c   Gollan, Jackie K ^d   Warden, Diane ^a   Nierenberg, Andrew A ^c   Gaynes, Bradley N ^e   Husain, Mustafa M ^a   Luther, James F ^b   Zisook, Sidney ^f   Rush, A John ^g  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; ESCITALOPRAM; FLUOXETINE; PAROXETINE; SERTRALINE;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONCISE HEALTH RISK TRACKING SCALE; DECREASED APPETITE; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FATIGUE; FEMALE; GUILT; HOPELESSNESS; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL CONCENTRATION; MENTAL HOSPITAL; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OPEN STUDY; PREDICTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOMETRY; PSYCHOMOTOR RETARDATION; RELIABILITY; RESTLESSNESS; RISK ASSESSMENT; SELF CONCEPT; SELF REPORT; SLEEP DISORDER; SOCIAL SUPPORT; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; WEIGHT CHANGE;

ADULT; DEPRESSIVE DISORDER, MAJOR; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SELF REPORT; SEROTONIN UPTAKE INHIBITORS; SUICIDAL IDEATION; SUICIDE; SUICIDE, ATTEMPTED;

EID: 79959580519     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m06837     Document Type: Article

References (29)

1. Moynihan R. FDA advisory panel calls for suicide warnings over new antidepressants. BMJ. 2004;328(7435):303. doi:10.136/bmj.328.7435.303-a PubMed
2. Healy D. Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors. Psychother Psychosom. 2003;72(2):71-79. doi:10.159/068691 PubMed (Pubitemid 36302475)
3. Mann JJ, Kapur S. The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy. Arch Gen Psychiatry. 1991;48(11):1027-1033. PubMed
4. Hansen L, Wilkinson DG. Drug induced akathisia, suicidal ideation and its treatment in the elderly. Int J Geriatr Psychiatry. 2001;16(2):231-233. doi:10.102/109-16(20102)16:2〈231:AID-GPS303〉3.0.CO;2-Y PubMed (Pubitemid 32166318)
5. Food and Drug Administration. Labeling change request letter for antidepressant medications.http://www.fda.gov/Drugs/DrugSafety/ InformationbyDrugClass/ucm096352.htm. Last updated February 29, 2009; Accessed May 5, 2011.
6. Miller IW, Norman WH, Bishop SB, et al. The Modified Scale for Suicidal Ideation: reliability and validity. J Consult Clin Psychol. 1986;54(5):724-725. doi:10.1037/02-06X.54.5.724 PubMed
7. Posner K, Oquendo MA, Gould M, et al. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry. 2007;164(7):1035-1043. doi:10.176/api.ajp.164.7.1035 PubMed (Pubitemid 47121392)
8. Beck AT, Weissman A, Lester D, et al. Classification of suicidal behaviors, 2: dimensions of suicidal intent. Arch Gen Psychiatry. 1976;33(7):835-837. PubMed
9. Zimmerman M, Mattia JI. A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. Arch Gen Psychiatry. 2001;58(8):787-794. doi:10.101/archpsyc.58.8.787 PubMed (Pubitemid 32717805)
10. Zimmerman M, Mattia JI. The Psychiatric Diagnostic Screening Questionnaire: development, reliability and validity. Compr Psychiatry. 2001;42(3):175-189. doi:10.1053/comp.201.23126 PubMed (Pubitemid 32410920)
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Press; 2000.
12. Trivedi MH, Rush AJ, Wisniewski SR, et al; STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40. doi:10.176/api.ajp.163.1.28 PubMed
13. Trivedi MH, Rush AJ, Gaynes BN, et al. Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care. Neuropsychopharmacology. 2007;32(12):2479-2489. doi:10.1038/sj.np.1301390 PubMed
14. Trivedi MH, Daly EJ. Measurement-based care for refractory depression: a clinical decision support model for clinical research and practice. Drug Alcohol Depend. 2007;88(suppl 2):S61-S71. doi:10.1016/j.drugalcdep.207.01.07 PubMed (Pubitemid 46528065)
15. Rush AJ, Carmody TJ, Reimitz PE. The Inventory of Depressive Symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. Int J Methods Psychiatr Res. 2000;9(2):45-59. doi:10.102/mpr.79
16. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573-583, Erratum 585. doi:10.1016/S06-323(02)0186-8 PubMed
17. Trivedi MH, Rush AJ, Ibrahim HM, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med. 2004;34(1):73-82. doi:10.1017/ S032917030107 PubMed (Pubitemid 38139442)
18. Levine J, Schooler NR. SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull. 1986;22(2):343-381. PubMed
19. Wisniewski SR, Rush AJ, Balasubramani GK, et al; for the STARD Investigators. Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract. 2006;12(2):71-79. doi:10.1097/0131746- 206030-02 PubMed (Pubitemid 44284089)
20. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56 PubMed
21. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278-296. PubMed
22. Sangha O, Stucki G, Liang MH, et al. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49(2):156-163. doi:10.102/art.1093 PubMed (Pubitemid 36418272)
23. Osman A, Gutierrez PM, Kopper BA, et al. The positive and negative suicide ideation inventory: development and validation. Psychol Rep. 1998;82(3, Pt 1):783-793. doi:10.246/PR0.82.3.783-793 PubMed (Pubitemid 128455905)
24. Beck AT, Epstein N, Brown G, et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893-897. doi:10.1037/02-06X.56.6.893 PubMed (Pubitemid 19008360)
25. Beck AT, Steer RA. Beck Anxiety Inventory Manual. San Antonio, TX: Psychological Corporation; 1990.
26. Wetzel RD. Hopelessness, depression, and suicide intent. Arch Gen Psychiatry. 1976;33(9):1069-1073. PubMed
27. Mundt JC, Greist JH, Gelenberg AJ, et al. Feasibility and validation of a computer-automated Columbia-Suicide Severity Rating Scale using interactive voice response technology. J Psychiatr Res. 2010;44(16):1224-1228. doi:10.1016/j.jpsychires.2010.04.025 PubMed
28. Brent DA, Greenhill LL, Compton S, et al. The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial. J Am Acad Child Adolesc Psychiatry. 2009;48(10):987-996. doi:10.1097/CHI.0b013e3181b5dbe4 PubMed
29. Brent DA, Emslie GJ, Clarke GN, et al. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. Am J Psychiatry. 2009;166(4):418-426.